Regeneron Pharmaceuticals Inc. buy Heureka
Summary
This prediction ended on 31.03.20 with a price of €432.50. The BUY prediction by Heureka finished with a performance of 3.04%. Heureka has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | 0.140% | 0.140% | 39.493% | 88.566% |
iShares Core DAX® | 1.665% | 1.692% | 18.093% | 15.353% |
iShares Nasdaq 100 | -0.475% | 1.483% | 27.860% | 36.314% |
iShares Nikkei 225® | 2.620% | 4.475% | 17.651% | 10.750% |
iShares S&P 500 | -0.091% | 1.099% | 24.873% | 36.740% |
Comments by Heureka for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
In the thread Trading Regeneron Pharmaceuticals Inc.
Stopped prediction by Heureka for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
16.04.20
04.11.21
17.12.20
Regeneron Pharmaceuticals Inc.
01.04.20
15.04.20
15.04.20
Regeneron Pharmaceuticals Inc.
19.03.20
25.03.20
25.03.20
Regeneron Pharmaceuticals Inc.
12.03.20
16.03.20
16.03.20